During the past decade, Spital Lotus SRL conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spital Lotus SRL" #1 collaborator was "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator, "Chinese Thoracic Oncology Group" with 1 trials as a collaborator, "Dutch Society of Physicians for Pulmonology and Tuberculosis" with 1 trials as a collaborator and "Fundación GECP" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Spital Lotus SRL" are "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Spital Lotus SRL" in a lesser frequency.

Most popular intervention types in "Spital Lotus SRL" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "Docetaxel" (1 trials), "MEDI4736" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spital Lotus SRL" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Spital Lotus SRL". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Spital Lotus SRL, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Spital Lotus SRL, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".